Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial

2012192 citationsJournal Articlebronze Open Access

Authors

Ludmila Shulgina · University of East Anglia

Anthony Cahn · Bedford Hospital NHS Trust

Edwin R. Chilvers · Papworth Hospital

Helen Parfrey · University of Cambridge

Allan Clark · University of East Anglia

Ed Wilson · University of East Anglia

Orion P. Twentyman ·

Abstract

The addition of co-trimoxazole therapy to standard treatment for fibrotic idiopathic interstitial pneumonia had no effect on lung function but resulted in improved quality of life and a reduction in mortality in those adhering to treatment. ISRCTN22201583.

Topics & Keywords

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Sarcoidosis and Beryllium Toxicity Research Respiratory and Cough-Related Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Thorax

Volume 68, Issue 2, pp. 155-162

DOI: 10.1136/thoraxjnl-2012-202403

Field-Weighted Citation Impact: 10.28